NCT02518750 Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma Status TERMINATED Phase PHASE2
NCT02518113 A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL Status COMPLETED Phase PHASE1/PHASE2
NCT02517021 A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting Status COMPLETED Phase PHASE3
NCT02516423 Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone Status TERMINATED Phase PHASE3
NCT02514382 Wild-Type Reovirus, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT02513186 Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation Status COMPLETED Phase PHASE1
NCT02508402 Effect Of Intra-muscular Administration of Dexamethasone in Induction of Labour Status UNKNOWN Phase PHASE4
NCT02497378 A Study of JNJ-54767414 (Daratumumab) in Combination With Bortezomib and Dexamethasone (D-Vd) in Japanese Participants With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT02496299 Effect of Dexamethasone Added To Bupivacaine During Caudal Block Status UNKNOWN Phase PHASE2
NCT02495922 A Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma Status COMPLETED Phase PHASE3
NCT02494882 Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02492750 Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma Status COMPLETED Phase PHASE1
NCT02491632 Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT02491411 Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel Status TERMINATED Phase NA
NCT02484911 Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting Status COMPLETED Phase PHASE3
NCT02477215 Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT02473042 Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV) Status COMPLETED Phase NA
NCT02471911 KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma Status COMPLETED Phase PHASE1